nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A paradigm shift in platelet transfusion therapy
|
Cho, Jaehyung |
|
|
125 |
23 |
p. 3523-3525 |
artikel |
2 |
Atypical HUS may become a diagnosis of inclusion
|
Sadler, J. Evan |
|
|
125 |
23 |
p. 3525-3526 |
artikel |
3 |
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia
|
Selimoglu-Buet, Dorothée |
|
|
125 |
23 |
p. 3618-3626 |
artikel |
4 |
Comparative analysis of human ex vivo–generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale
|
Wang, Yuhuan |
|
|
125 |
23 |
p. 3627-3636 |
artikel |
5 |
DUB-ling down on B-cell malignancies
|
Boise, Lawrence H. |
|
|
125 |
23 |
p. 3522-3523 |
artikel |
6 |
Editorial Board
|
|
|
|
125 |
23 |
p. i |
artikel |
7 |
Emerging EPO and EPO receptor regulators and signal transducers
|
Kuhrt, David |
|
|
125 |
23 |
p. 3536-3541 |
artikel |
8 |
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8
|
Gounari, Maria |
|
|
125 |
23 |
p. 3580-3587 |
artikel |
9 |
Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1
|
Touzot, Fabien |
|
|
125 |
23 |
p. 3563-3569 |
artikel |
10 |
Gene therapy outpaces haplo for SCID-X1
|
Kohn, Donald B. |
|
|
125 |
23 |
p. 3521-3522 |
artikel |
11 |
How does dapsone work in immune thrombocytopenia? Implications for dosing
|
Hill, Quentin A. |
|
|
125 |
23 |
p. 3666-3668 |
artikel |
12 |
How I treat priapism
|
Anele, Uzoma A. |
|
|
125 |
23 |
p. 3551-3558 |
artikel |
13 |
Indicators of true intracerebral hemorrhage: hematoidin, siderophage, and erythrophage
|
Gulati, Rohit |
|
|
125 |
23 |
p. 3664 |
artikel |
14 |
Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization
|
Daniels, Geoff |
|
|
125 |
23 |
p. 3651-3654 |
artikel |
15 |
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
|
Aoki, Tomohiro |
|
|
125 |
23 |
p. 3559-3562 |
artikel |
16 |
Modified Ham test for atypical hemolytic uremic syndrome
|
Gavriilaki, Eleni |
|
|
125 |
23 |
p. 3637-3646 |
artikel |
17 |
Myeloma cell–derived Runx2 promotes myeloma progression in bone
|
Trotter, Timothy N. |
|
|
125 |
23 |
p. 3598-3608 |
artikel |
18 |
NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT
|
Karimi, Mobin A. |
|
|
125 |
23 |
p. 3655-3663 |
artikel |
19 |
PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia
|
Dang, Jinjun |
|
|
125 |
23 |
p. 3609-3617 |
artikel |
20 |
Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea
|
Okam, Maureen M. |
|
|
125 |
23 |
p. 3668-3669 |
artikel |
21 |
Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency
|
Bouchard, Beth A. |
|
|
125 |
23 |
p. 3647-3650 |
artikel |
22 |
RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation
|
Kuvardina, Olga N. |
|
|
125 |
23 |
p. 3570-3579 |
artikel |
23 |
Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia
|
Steensma, David P. |
|
|
125 |
23 |
p. 3669-3671 |
artikel |
24 |
Survival in patients with familial and sporadic myeloproliferative neoplasms
|
Hultcrantz, Malin |
|
|
125 |
23 |
p. 3665-3666 |
artikel |
25 |
Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies
|
Peterson, Luke F. |
|
|
125 |
23 |
p. 3588-3597 |
artikel |
26 |
TGF-β signaling in the control of hematopoietic stem cells
|
Blank, Ulrika |
|
|
125 |
23 |
p. 3542-3550 |
artikel |
27 |
The dark side of T memory stem cells
|
Gattinoni, Luca |
|
|
125 |
23 |
p. 3519-3520 |
artikel |
28 |
T memory stem cells are the hierarchical apex of adult T-cell leukemia
|
Nagai, Yuya |
|
|
125 |
23 |
p. 3527-3535 |
artikel |